AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
3.450
-0.140 (-3.90%)
At close: Mar 6, 2026, 4:00 PM EST
3.495
+0.045 (1.30%)
After-hours: Mar 6, 2026, 7:55 PM EST
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $1.05 billion as of March 6, 2026. Its market cap has increased by 12.77% in one year.
Market Cap
1.05B
Enterprise Value
655.30M
1-Year Change
12.77%
Ranking
Category
Stock Price
$3.45
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $1.05B, a decrease of -93.32%. That is a compound annual growth rate of -40.37%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taysha Gene Therapies | 1.23B |
| Bicara Therapeutics | 1.20B |
| DBV Technologies | 1.20B |
| Precigen | 1.19B |
| Inventiva | 1.17B |
| Aktis Oncology | 1.08B |
| Pharming Group | 1.07B |
| ArriVent BioPharma | 1.04B |